IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v528y2015i7580d10.1038_nature16071.html
   My bibliography  Save this article

Brain tumour cells interconnect to a functional and resistant network

Author

Listed:
  • Matthias Osswald

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Erik Jung

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Felix Sahm

    (Institute of Pathology, Ruprecht-Karls University Heidelberg, INF 224
    Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), INF 224)

  • Gergely Solecki

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Varun Venkataramani

    (Institute of Anatomy and Cell Biology, Heidelberg University, INF 307)

  • Jonas Blaes

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Sophie Weil

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Heinz Horstmann

    (Institute of Anatomy and Cell Biology, Heidelberg University, INF 307)

  • Benedikt Wiestler

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Klinikum rechts der Isar der Technischen Universität München)

  • Mustafa Syed

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Lulu Huang

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Miriam Ratliff

    (Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Neurosurgery Clinic, University Hospital Heidelberg, INF 400)

  • Kianush Karimian Jazi

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Felix T. Kurz

    (University Hospital Heidelberg, INF 400)

  • Torsten Schmenger

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Dieter Lemke

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Miriam Gömmel

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Martin Pauli

    (Institute of Physiology, University of Würzburg)

  • Yunxiang Liao

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Peter Häring

    (German Cancer Research Center (DKFZ))

  • Stefan Pusch

    (Institute of Pathology, Ruprecht-Karls University Heidelberg, INF 224
    Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), INF 224)

  • Verena Herl

    (Institute of Cellular Neurosciences, Medical Faculty, University of Bonn, Sigmund-Freud-Strasse 25)

  • Christian Steinhäuser

    (Institute of Cellular Neurosciences, Medical Faculty, University of Bonn, Sigmund-Freud-Strasse 25)

  • Damir Krunic

    (Light Microscopy Facility, German Cancer Research Center (DKFZ))

  • Mostafa Jarahian

    (German Cancer Research Center (DKFZ))

  • Hrvoje Miletic

    (University of Bergen, Jonas Lies vei 91)

  • Anna S. Berghoff

    (Institute of Neurology, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, CNS Unit, Medical University of Vienna
    Comprehensive Cancer Center, CNS Unit, Medical University of Vienna)

  • Oliver Griesbeck

    (Tools For Bio-Imaging, Max-Planck-Institute of Neurobiology)

  • Georgios Kalamakis

    (Institute of Physiology II, Eberhard Karls University of Tübingen)

  • Olga Garaschuk

    (Institute of Physiology II, Eberhard Karls University of Tübingen)

  • Matthias Preusser

    (Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, CNS Unit, Medical University of Vienna
    Comprehensive Cancer Center, CNS Unit, Medical University of Vienna)

  • Samuel Weiss

    (Hotchkiss Brain Institute, Faculty of Medicine, University of Calgary, Calgary
    Faculty of Medicine, University of Calgary
    Clark Smith Brain Tumor Research Centre, Southern Alberta Cancer Research Institute, Faculty of Medicine, University of Calgary)

  • Haikun Liu

    (Helmholtz Young Investigator Group, Normal and Neoplastic CNS Stem Cells, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), INF 280)

  • Sabine Heiland

    (University Hospital Heidelberg, INF 400)

  • Michael Platten

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Peter E. Huber

    (CCU Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), INF 280
    University Hospital Heidelberg)

  • Thomas Kuner

    (Institute of Anatomy and Cell Biology, Heidelberg University, INF 307)

  • Andreas von Deimling

    (Institute of Pathology, Ruprecht-Karls University Heidelberg, INF 224
    Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), INF 224)

  • Wolfgang Wick

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Frank Winkler

    (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, INF 400
    Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

Abstract

Astrocytic brain tumours, including glioblastomas, are incurable neoplasms characterized by diffusely infiltrative growth. Here we show that many tumour cells in astrocytomas extend ultra-long membrane protrusions, and use these distinct tumour microtubes as routes for brain invasion, proliferation, and to interconnect over long distances. The resulting network allows multicellular communication through microtube-associated gap junctions. When damage to the network occurred, tumour microtubes were used for repair. Moreover, the microtube-connected astrocytoma cells, but not those remaining unconnected throughout tumour progression, were protected from cell death inflicted by radiotherapy. The neuronal growth-associated protein 43 was important for microtube formation and function, and drove microtube-dependent tumour cell invasion, proliferation, interconnection, and radioresistance. Oligodendroglial brain tumours were deficient in this mechanism. In summary, astrocytomas can develop functional multicellular network structures. Disconnection of astrocytoma cells by targeting their tumour microtubes emerges as a new principle to reduce the treatment resistance of this disease.

Suggested Citation

  • Matthias Osswald & Erik Jung & Felix Sahm & Gergely Solecki & Varun Venkataramani & Jonas Blaes & Sophie Weil & Heinz Horstmann & Benedikt Wiestler & Mustafa Syed & Lulu Huang & Miriam Ratliff & Kianu, 2015. "Brain tumour cells interconnect to a functional and resistant network," Nature, Nature, vol. 528(7580), pages 93-98, December.
  • Handle: RePEc:nat:nature:v:528:y:2015:i:7580:d:10.1038_nature16071
    DOI: 10.1038/nature16071
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature16071
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature16071?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ryan Thiessen & Thomas Hillen, 2021. "Anisotropic Network Patterns in Kinetic and Diffusive Chemotaxis Models," Mathematics, MDPI, vol. 9(13), pages 1-22, July.
    2. Marc Cicero Schubert & Stella Judith Soyka & Amr Tamimi & Emanuel Maus & Julian Schroers & Niklas Wißmann & Ekin Reyhan & Svenja Kristin Tetzlaff & Yvonne Yang & Robert Denninger & Robin Peretzke & Ca, 2024. "Deep intravital brain tumor imaging enabled by tailored three-photon microscopy and analysis," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    3. Ling Hai & Dirk C. Hoffmann & Robin J. Wagener & Daniel D. Azorin & David Hausmann & Ruifan Xie & Magnus-Carsten Huppertz & Julien Hiblot & Philipp Sievers & Sophie Heuer & Jakob Ito & Gina Cebulla & , 2024. "A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1," Nature Communications, Nature, vol. 15(1), pages 1-29, December.
    4. Florent Peglion & Lavinia Capuana & Isabelle Perfettini & Laurent Boucontet & Ben Braithwaite & Emma Colucci-Guyon & Emie Quissac & Karin Forsberg-Nilsson & Flora Llense & Sandrine Etienne-Manneville, 2022. "PTEN inhibits AMPK to control collective migration," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    5. Yuanning Zheng & Francisco Carrillo-Perez & Marija Pizurica & Dieter Henrik Heiland & Olivier Gevaert, 2023. "Spatial cellular architecture predicts prognosis in glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    6. Rana Salam & Alexa Saliou & Franck Bielle & Mathilde Bertrand & Christophe Antoniewski & Catherine Carpentier & Agusti Alentorn & Laurent Capelle & Marc Sanson & Emmanuelle Huillard & Léa Bellenger & , 2023. "Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    7. Chaitali Chakraborty & Itzel Nissen & Craig A. Vincent & Anna-Carin Hägglund & Andreas Hörnblad & Silvia Remeseiro, 2023. "Rewiring of the promoter-enhancer interactome and regulatory landscape in glioblastoma orchestrates gene expression underlying neurogliomal synaptic communication," Nature Communications, Nature, vol. 14(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:528:y:2015:i:7580:d:10.1038_nature16071. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.